These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 29684469)

  • 1. Imaging techniques to study drug transporter function in vivo.
    Tournier N; Stieger B; Langer O
    Pharmacol Ther; 2018 Sep; 189():104-122. PubMed ID: 29684469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of Human Membrane Transporters: Drug Disposition and Pharmacogenetics.
    Mooij MG; Nies AT; Knibbe CA; Schaeffeler E; Tibboel D; Schwab M; de Wildt SN
    Clin Pharmacokinet; 2016 May; 55(5):507-24. PubMed ID: 26410689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro and in vivo approaches to characterize transporter-mediated disposition in drug discovery.
    Feng B; Varma MV; Costales C; Zhang H; Tremaine L
    Expert Opin Drug Discov; 2014 Aug; 9(8):873-90. PubMed ID: 24857286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Imaging in the study of membrane transporters.
    Kusuhara H
    Clin Pharmacol Ther; 2013 Jul; 94(1):33-6. PubMed ID: 23615038
    [No Abstract]   [Full Text] [Related]  

  • 5. Implications of the dominant role of transporters in drug uptake by cells.
    Dobson PD; Lanthaler K; Oliver SG; Kell DB
    Curr Top Med Chem; 2009; 9(2):163-81. PubMed ID: 19200003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transporter-mediated drug delivery: recent progress and experimental approaches.
    Sai Y; Tsuji A
    Drug Discov Today; 2004 Aug; 9(16):712-20. PubMed ID: 15341785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intestinal drug transporters: an overview.
    Estudante M; Morais JG; Soveral G; Benet LZ
    Adv Drug Deliv Rev; 2013 Oct; 65(10):1340-56. PubMed ID: 23041352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of imaging to assess the activity of hepatic transporters.
    Hernández Lozano I; Langer O
    Expert Opin Drug Metab Toxicol; 2020 Feb; 16(2):149-164. PubMed ID: 31951754
    [No Abstract]   [Full Text] [Related]  

  • 9. Recent progress in in vivo phenotyping technologies for better prediction of transporter-mediated drug-drug interactions.
    Maeda K
    Drug Metab Pharmacokinet; 2020 Feb; 35(1):76-88. PubMed ID: 31948854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Using positron emission tomography to study transporter-mediated drug-drug interactions in tissues.
    Wulkersdorfer B; Wanek T; Bauer M; Zeitlinger M; Müller M; Langer O
    Clin Pharmacol Ther; 2014 Aug; 96(2):206-13. PubMed ID: 24682030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The kidney--the body's playground for drugs: an overview of renal drug handling with selected clinical correlates.
    Perri D; Ito S; Rowsell V; Shear NH
    Can J Clin Pharmacol; 2003; 10(1):17-23. PubMed ID: 12687033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Application of Model-Based Approaches to Evaluate Hepatic Transporter-Mediated Drug Clearance: In vitro, In vivo, and In vitro-In vivo Extrapolation.
    Liu Z; Liu K
    Curr Drug Metab; 2016; 17(5):456-68. PubMed ID: 26750112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatic drug transporters: the journey so far.
    Riley RJ; Foley SA; Barton P; Soars MG; Williamson B
    Expert Opin Drug Metab Toxicol; 2016; 12(2):201-16. PubMed ID: 26670591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Navigating Transporter Sciences in Pharmacokinetics Characterization Using the Extended Clearance Classification System.
    El-Kattan AF; Varma MVS
    Drug Metab Dispos; 2018 May; 46(5):729-739. PubMed ID: 29496721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent progresses in the experimental methods and evaluation strategies of transporter functions for the prediction of the pharmacokinetics in humans.
    Kitamura S; Maeda K; Sugiyama Y
    Naunyn Schmiedebergs Arch Pharmacol; 2008 Jun; 377(4-6):617-28. PubMed ID: 18536908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stereoselectivity of chiral drug transport: a focus on enantiomer-transporter interaction.
    Zhou Q; Yu LS; Zeng S
    Drug Metab Rev; 2014 Aug; 46(3):283-90. PubMed ID: 24796860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary hepatocyte cultures as prominent in vitro tools to study hepatic drug transporters.
    Ramboer E; Vanhaecke T; Rogiers V; Vinken M
    Drug Metab Rev; 2013 May; 45(2):196-217. PubMed ID: 23368091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transporter-Enzyme Interplay: Deconvoluting Effects of Hepatic Transporters and Enzymes on Drug Disposition Using Static and Dynamic Mechanistic Models.
    Varma MV; El-Kattan AF
    J Clin Pharmacol; 2016 Jul; 56 Suppl 7():S99-S109. PubMed ID: 27385183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of drug transporter interactions in drug discovery and development.
    Lai Y; Sampson KE; Stevens JC
    Comb Chem High Throughput Screen; 2010 Feb; 13(2):112-34. PubMed ID: 20053160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imaging Probes and Modalities for the Study of Solute Carrier O (SLCO)-Transport Function In Vivo.
    Marie S; Cisternino S; Buvat I; Declèves X; Tournier N
    J Pharm Sci; 2017 Sep; 106(9):2335-2344. PubMed ID: 28454744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.